Our weekly summary of news and developments across global IPO markets.
248 editions
Bill Ackman targets a massive $5 billion IPO for a new closed-end fund, while sports tech firm Enhanced agrees to a $1.2 billion SPAC merger. IPOX® CEO Josef Schuster notes the SPAC model’s enduring relevance following the deal. Elsewhere, the UK introduces stamp duty relief to revitalize London listings, and Hong Kong sees a flurry of activity with Syngenta’s potential pivot and new filings from Suzhou Novosense and Muyuan Foods.
Read editionAsia-Pacific dominates this week, led by SBI Shinsei Bank’s potential $2.4 billion Tokyo relisting and CK Hutchison’s plan for a $2 billion AS Watson float. Singapore sees UltraGreen.ai targeting $400 million, while the U.S. pipeline heats up with crypto giant Kraken filing for a 2026 debut and Grayscale seeking a NYSE spot. MENA activity is strong with Saudi Global Ports eyeing $1 billion. Meanwhile, Uzbekistan’s sovereign fund prepares for a historic London listing, signaling renewed global momentum across diverse sectors.
Read editionGlobal IPO activity intensifies with major U.S. filings including Blackstone-backed Copeland ($4.75B revenue), Grayscale ($35B AUM), and SoftBank-backed Klook ($417M revenue). Asia-Pacific markets see SBI Shinsei Bank's $2.1 billion Tokyo offering and Kbank's third KOSPI attempt. European developments feature BASF's 2027 Frankfurt listing plans and Bending Spoons eyeing a 2026 U.S. IPO at $11 billion valuation. IPOX® analysts highlighted travel sector opportunities and cautioned about market volatility.
Read editionThis week's IPO activity featured significant U.S. SPAC deals, including Dubai hookah maker AIR's $1.75 billion Nasdaq listing and Xanadu Quantum's $3.6 billion merger. Aeromexico successfully debuted on NYSE at a $2.8 billion valuation. International markets saw Malaysia's Sunway Healthcare planning a $1 billion IPO, while Germany's Mobile.de attracted interest ahead of a potential €10 billion listing. IPOX® analysts highlighted SPAC revival momentum and MENA market valuation challenges.
Read editionOpenAI targets a record-breaking $1 trillion valuation, Medline files for a $50 billion listing, and Gloo Holdings readies a Nasdaq debut at $873 million. Meanwhile, the UK’s Doncasters eyes a 2026 New York offering, KR1 plans a London uplisting, and Pollon Life, backed by Jack Ma, files in Hong Kong, signaling renewed global confidence in major listings across regions.
Read editionIn the U.S., a potential Fannie Mae IPO by late 2025 and WestJet’s planned listing highlight optimism despite the government shutdown halting DeepGreenX’s debut. Europe sees EDF exploring a €7–10B Edison IPO and Poland’s Empik eyeing €200M. Asia-Pacific dominates with Yangtze Memory’s possible $40B listing, Haier’s $500M IoT spinout, and multiple Hong Kong, Singapore, and Tokyo deals. In MENA, Dubizzle postponed its $2B Dubai IPO amid weak market sentiment.
Read editionIPO activity accelerates despite the U.S. government shutdown. In the U.S., Medline targets a ~$5B float, PayPay eyes a December listing above $20B, Navan and Beta advance sizable offerings, and Exzeo launches on NYSE. Europe sees CSG and Shawbrook preparing deals, while Asia-Pacific features Seres, WeRide, Rakuten Card, Coca-Cola’s HCCB, and I-Mab’s dual listing. MENA’s Dubizzle opens a ~$600M Dubai IPO. IPOX® CEO Josef Schuster urges flexible terms amid volatility.
Read editionGlobal IPO activity is accelerating across regions, led by biotech and AI firms in the U.S., major industrial listings in Europe, and robotics and infrastructure plays in Asia. MENA markets also see renewed momentum with Dubai and Johannesburg offerings on deck. Commentary from IPOX® CEO Josef Schuster and IPOX® Analyst Lukas Muehlbauer underscores strong investor sentiment and strategic timing as issuers navigate regulatory hurdles and capitalize on market windows.
Read editionGlobal IPO markets are regaining momentum across regions, with billion-dollar deals in the U.S., Europe, Asia, and MENA. Highlights include Verisure’s €3.1B raise in Stockholm, MRI Software’s potential $10B U.S. float, and Ottobock’s €800M Frankfurt listing. Meanwhile, fintech Wealthfront, Navan, and University of Phoenix’s owner have filed in the U.S. Strong demand persists, though risks remain, as IPOX® analysts warn pricing discipline and U.S. government shutdown delays could stall activity.
Read edition